Page last updated: 2024-12-04

prephenic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

prephenic acid: nonaromatic biosynthetic intermediate, probable immediate precursor of aromatic systems such as phenylalanine, tyrosine, tannins, flavanoids; isolated from cultures of mutant E coli; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

(1s,4s)-prephenic acid : A prephenic acid having (1s,4s)-cis-configuration. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

prephenic acid : An oxo dicarboxylic acid that consists of 4-hydroxycyclohexa-2,5-diene-1-carboxylic acid substituted by a 2-carboxy-2-oxoethyl group at position 1. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID1028
CHEBI ID16666
CHEBI ID84387
SCHEMBL ID9885026
SCHEMBL ID1703158
SCHEMBL ID1703157
MeSH IDM0047169

Synonyms (35)

Synonym
1-carboxy-4-hydroxy-2,5-cyclohexadiene-1-pyruvic acid
1-carboxy-4-hydroxy-alpha-oxo-2,5-cyclohexadiene-1-propanoic acid
CHEBI:16666
2,5-cyclohexadiene-1-pyruvic acid, 1-carboxy-4-hydroxy-
2,5-cyclohexadiene-1-pyruvic acid, 1-carboxy-4-hydroxy- (6ci,7ci,8ci)
2,5-cyclohexadiene-1-propanoic acid, 1-carboxy-4-hydroxy-a-oxo- (9ci)
2,5-cyclohexadiene-1-propanoic acid, 1-carboxy-4-hydroxy-alpha-oxo-
prephenic acid
126-49-8
PREPHENATE ,
C00254
PRE ,
D0CAEB4E-FD01-4AD2-9DC4-AABEBF5AED8A
DB08427
cis-1-carboxy-4-hydroxy-alpha-oxo-2,5-cyclohexadiene-1-propanoic acid
cis-prephenic acid
(1s,4s)-prephenic acid
BMSE000108
SCHEMBL9885026
z66b98z97i ,
unii-z66b98z97i
cis-1-carboxy-4-hydroxy-.alpha.-oxo-2,5-cyclohexadiene-1-propanoic acid
prephenic acid, cis
prephenic acid [mi]
87664-40-2
(1s,4s)-1-(2-carboxy-2-oxoethyl)-4-hydroxycyclohexa-2,5-diene-1-carboxylic acid
CHEBI:84387
cis-1-(2-carboxy-2-oxoethyl)-4-hydroxycyclohexa-2,5-diene-1-carboxylic acid
SCHEMBL1703158
SCHEMBL1703157
1-(2-carboxy-2-oxoethyl)-4-hydroxycyclohexa-2,5-diene-1-carboxylic acid
DTXSID60894109
DTXSID70894110
FPWMCUPFBRFMLH-UHFFFAOYSA-N
Q2598317
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
oxo dicarboxylic acidAny dicarboxylic acid carrying one or more oxo groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (4)

PathwayProteinsCompounds
Tyrosine Biosynthesis519
Phenylalanine Biosynthesis39
Phenylalanine Metabolism1013
phenylalanine biosynthesis06
Phenylalanine biosynthesis I08

Research

Studies (69)

TimeframeStudies, This Drug (%)All Drugs %
pre-199017 (24.64)18.7374
1990's7 (10.14)18.2507
2000's20 (28.99)29.6817
2010's23 (33.33)24.3611
2020's2 (2.90)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.08

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.08 (24.57)
Research Supply Index4.25 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index39.34 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.08)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (2.90%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other67 (97.10%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]